Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400)
The study is being conducted at hundreds of sites in the United States. A full list of sites at which Lung-MAP is currently being conducted is available on the website
Squamous cell lung cancer. Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.
June 16, 2014 - January 1, 2022
Sign up for the latest lung health news delivered right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.